Valuation : Artivion, Inc.

Market Cap 132.08Cr 113.95Cr 107.34Cr 98Cr 182.8Cr 12TCr 184.17Cr 1.27TCr 493.19Cr 6.38TCr 495.98Cr 485.13Cr 21TCr P/E 2026 *
-100x
P/E 2027 * 93.8x
Enterprise Value 132.08Cr 113.95Cr 107.34Cr 98Cr 182.8Cr 12TCr 184.17Cr 1.27TCr 493.19Cr 6.38TCr 495.98Cr 485.13Cr 21TCr EV / Sales 2026 *
2.69x
EV / Sales 2027 * 2.43x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day-1.51%
1 week-1.80%
Current month-1.04%
1 month-2.77%
3 months+30.80%
6 months-30.71%
Current year-41.44%
1 week 25.86
Extreme 25.86
27.95
1 month 25.79
Extreme 25.7875
30.14
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Director/Board Member 61 01/05/2012
Date Insider Type Main position Quantity % Market Cap. Importance
19/08/26 Sell

Chief Executive Officer

-70,000 0.1442%
14/08/26 Sell

General Counsel

-616 0.0013%
14/08/26 Sell

Chief Financial Officer

-715 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.51%-1.80%-38.89%+72.66% 132.08Cr
+1.83%-2.92%-15.74%+9.80% 19TCr
+1.06%+0.96%-0.46%+15.84% 12TCr
+1.53%+2.74%+14.21%+94.81% 6.32TCr
-1.89%-2.30%+26.76%+50.42% 5.2TCr
+0.68%-0.80%+0.28%-30.85% 5.1TCr
-0.17%+0.74%+20.62%-10.67% 3.4TCr
+3.13%+4.22% - - 3.08TCr
+1.10%-1.84%+40.92%-14.91% 2.38TCr
-2.97%-4.91%-7.98%+11.64% 2.34TCr
Average +0.29%-1.22%+4.41%+22.08% 5.86TCr
Weighted average by Cap. +0.95%-2.59%+1.30%+18.74%

Financials

2026 *2027 *
Net sales 49Cr 42Cr 40Cr 36Cr 68Cr 4.63TCr 68Cr 471.84Cr 183.12Cr 2.37TCr 184.15Cr 180.13Cr 7.78TCr 54Cr 47Cr 44Cr 40Cr 75Cr 5.13TCr 76Cr 522.65Cr 202.84Cr 2.62TCr 203.98Cr 199.52Cr 8.62TCr
Net income -1.21Cr -1.04Cr -98.22L -89.49L -1.67Cr -114.17Cr -1.69Cr -12Cr -4.51Cr -58Cr -4.54Cr -4.44Cr -191.74Cr 1.48Cr 1.28Cr 1.2Cr 1.1Cr 2.05Cr 139.77Cr 2.06Cr 14Cr 5.52Cr 71Cr 5.56Cr 5.43Cr 234.74Cr
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
03/26/03 $26.71 -1.40% 1,67,611
01/26/01 $27.09 +0.37% 6,75,100
31/26/31 $26.99 +0.82% 6,69,065
28/26/28 $26.77 +0.37% 4,66,495
27/26/27 $26.67 -1.95% 4,40,843
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
27.09USD
Average target price
42.15USD
Spread / Average Target
+55.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock